CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan · Delayed Price · Currency is TWD 91.50
-0.30 (-0.33%)
Jun 25, 2026, 1:30 PM CST
CH Biotech R&D Market Cap
CH Biotech R&D has a market cap or net worth of 9.41 billion as of June 25, 2026. Its market cap has increased by 16.12% in one year.
Market Cap
9.41B
Enterprise Value
9.40B
Revenue
1.84B
Ranking
n/a
PE Ratio
19.18
Stock Price
91.50
Market Cap Chart
Since July 2, 2015, CH Biotech R&D's market cap has increased from 7.47B to 9.41B, an increase of 25.92%. That is a compound annual growth rate of 2.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 9.41B | 1.67% |
| Dec 31, 2025 | 9.25B | 11.39% |
| Dec 31, 2024 | 8.31B | 0.37% |
| Dec 29, 2023 | 8.28B | 13.05% |
| Dec 30, 2022 | 7.32B | 42.15% |
| Dec 30, 2021 | 5.15B | 20.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nan Ya Plastics | 1.24T |
| Formosa Plastics | 346.93B |
| Formosa Chemicals & Fibre | 337.49B |
| China Steel | 294.93B |
| International CSRC Investment Holdings | 9.89B |
| Keding Enterprises | 9.78B |
| Tang Eng Iron Works | 9.77B |
| Taiwan Hopax Chemicals Manufacturing | 9.52B |